Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsIpcalaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Bull's Eye: Buy HDIL, Ipca Labs, Unitech

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Bull's Eye: Short Voltas, Maruti, Titan, buy ITC, IGL

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Bull's Eye: Buy Bata, United Spirits, Godrej Cons

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Ipca Labs, Lupin top picks in pharma space: Agarwal

      Ipca Labs and Lupin are top picks in pharma space, says Rajesh Agarwal, Head of Research, Eastern Financiers.

    • Bull's Eye: Buy Kingfisher, Wipro; sell SAIL, Dish TV

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Buy Ipca Laboratories, says Sukhani

      Buy Ipca Laboratories, says Sudarshan Sukhani of technicaltrends.com.

    • Ipca Labs has target of Rs 300: Sukhani

      Ipca Laboratories has target of Rs 300, says Sudarshan Sukhani, Technical Trends.

    • Buy Ipca Labs, says Rajesh Agarwal

      Buy Ipca Labs, says Rajesh Agarwal of Eastern Financiers

    • Bull's Eye: 12 trading ideas for the day

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Buy Ipca Lab with target of Rs 341: Joshi

      Buy Ipca Lab with a target of Rs 341, says Sharmila Joshi of Fairwealth Securities.

    • 12 trading strategies for intra-day

      In an interview to CNBC-TV18, Sharmila Joshi of Fairwealth Securities; Sanjay Vaid of SBI Capital Securities and Jagannadham Thunuguntla, Head of Research, SMC Global, share their stock strategies for intra-day trade.

    • IPCA Labs a top pick in pharma space: Bandyopadhyay

      IPCA Labs a top pick in pharma space, says Sudip Bandyopadhyay, MD & CEO, Destimoney Securities.

    • Lupin, Cadila may give excellent returns: PN Vijay

      Lupin and Cadila may give excellent returns, says PN Vijay, Portfolio Manager.

    • Ipca labs can test Rs 450: PN Vijay

      Ipca labs can test Rs 450 in about 15 to 18 months, says PN Vijay, Portfolio Manager.

    • Bandyopadhyay positive on pharma, auto ancillaries

      Sudeep Bandyopadhyay, President, Destimoney Securities is positive on pharma, auto ancillaries.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347